BCL9 and colorectal carcinoma: Using identical mice xenograft models, a group of scientists from China described that BCL9 inhibition attenuated CRC growth via inhibiting TAM polarization from M0 to M2 phenotype that interfered with inflammatory actions of M0 and M1 TAMs.